Additional Details

  • A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease

    GSK Investigational Site
    Denison TX. 75020
    View Details

  • A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease

    GSK Investigational Site
    El Paso TX. 79902
    View Details

  • A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease

    GSK Investigational Site
    Philadelphia PA. 19104
    View Details

  • A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease

    GSK Investigational Site
    Ann Arbor MI. 48109
    View Details

  • A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease

    GSK Investigational Site
    Philadelphia PA. 19140
    View Details

  • A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease

    GSK Investigational Site
    Tucson AZ. 85724
    View Details

  • A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease

    GSK Investigational Site
    New York NY. 10021
    View Details

  • A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease

    GSK Investigational Site
    Chicago IL. 60611
    View Details

  • A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease

    GSK Investigational Site
    Scottsdale AZ. 85258
    View Details

  • A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease

    GSK Investigational Site
    Potsdam NY. 13676
    View Details

  • A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease

    GSK Investigational Site
    Upland CA. 91786
    View Details

  • A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease

    GSK Investigational Site
    Scottsdale AZ. 85259
    View Details

  • A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease

    GSK Investigational Site
    Aurora CO. 80033
    View Details

  • A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease

    GSK Investigational Site
    Houston TX. 77030
    View Details

  • A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease

    GSK Investigational Site
    New Brunswick NJ. 08901
    View Details

  • A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease

    GSK Investigational Site
    Cincinnati OH. 45206
    View Details

  • A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease

    GSK Investigational Site
    Los Angeles CA. 90095
    View Details

  • A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease

    GSK Investigational Site
    Baltimore MD. 21224
    View Details

  • Mycophenolate Mofetil in Systemic Sclerosis With Subclinical Interstitial Lung Disease

    Institut Universitaire de Cardiologie et Pneumologie de Québec
    Quebec City QC.
    View Details

  • Mycophenolate Mofetil in Systemic Sclerosis With Subclinical Interstitial Lung Disease

    Jewish General Hospital - CIUSSS-COMTL
    Montreal QC. H3T 1E2
    View Details